
CCJ · NYSE
Consensus is Buy, with all 11 analysts supporting that rating. The only supplied target statistic is a mean of $129; the low and high targets are unavailable, so target clustering and the width of the spread cannot be measured. The evidence does not identify the most or least bullish analyst, and it supplies no analyst-specific revisions during the past week, leaving revision direction undetermined. The substantive disagreement is qualitative: bullish arguments emphasize Cameco’s intact 2026 plan, stronger long-term uranium contracting, protected contract value, and Westinghouse’s 91-reactor AP1000 pipeline, while bearish arguments focus on the 50% earnings miss, declining profit, and Saskatchewan disruptions.